Get the Stockscreener App
0.1987
0.95%
-0.0019
After Hours:
.20
0.0013
+0.65%
Lunai Bioworks Inc stock is traded at $0.1987, with a volume of 590.94K.
It is down -0.95% in the last 24 hours and down -16.27% over the past month.
Lunai Bioworks Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
See More
Previous Close:
$0.2006
Open:
$0.2
24h Volume:
590.94K
Relative Volume:
0.31
Market Cap:
$45.89M
Revenue:
-
Net Income/Loss:
$-67.01M
P/E Ratio:
-0.5844
EPS:
-0.34
Net Cash Flow:
$-8.50M
1W Performance:
-3.78%
1M Performance:
-16.27%
6M Performance:
-76.95%
1Y Performance:
-67.99%
1-Day Range:
$0.195
$0.207
1-Week Range:
$0.1823
$0.223
52-Week Range:
$0.1823
$2.10
Lunai Bioworks Inc Stock (RENB) Company Profile
Name
Lunai Bioworks Inc
Sector
Industry
Phone
45 39179840
Address
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Compare RENB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RENB
Lunai Bioworks Inc
|
0.1987 | 47.78M | 0 | -67.01M | -8.50M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Lunai Bioworks Inc Stock (RENB) Latest News
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - Lansing State Journal
$1.85M NIH Grant Powers Lunai Bioworks' AI Platform to Combat Alcohol Disorder Affecting 19M Americans - Stock Titan
Lunai Bioworks launches transformer-base platform to secure GenAI - Yahoo Finance
REN-B: Lunai Bioworks Unveils AI Platform to Ensure Biological S - GuruFocus
Top 3 Health Care Stocks You'll Regret Missing In Q3 - Benzinga
First-Ever AI Safety Platform: Lunai Bioworks Launches Transformer Tech to Secure Drug Discovery & Block Biothreat - Stock Titan
Lunai Bioworks (RENB) Restructures European Operations for Strat - GuruFocus
Lunai Bioworks Strengthens European Strategy Through Restructuring - PharmiWeb.com
Lunai Bioworks Strengthens European Strategy Through Restructuri - GuruFocus
Lunai Bioworks strengthens European strategy through restructuring - TipRanks
AI Drug Discovery Firm Lunai Bioworks Restructures European Business, Maintains Growth Strategy - Stock Titan
Lunai Bioworks subsidiary Gedi Cube B.V. files for bankruptcy in Amsterdam - Investing.com Australia
Renovaro Biosciences Faces Subsidiary Bankruptcy Impact - TipRanks
Lunai Bioworks subsidiary Gedi Cube B.V. files for bankruptcy in Amsterdam By Investing.com - Investing.com South Africa
Renovaro Inc. shares fall 13.53% after-hours following Lunai Bioworks IncGedi Cube B.V. bankruptcy. - AInvest
Lunai Bioworks IncGedi Cube B.V. declared bankrupt by Court of AmsterdamSEC filing - MarketScreener
Lunai partners with defense firm to develop chemical weapons countermeasures - Investing.com Australia
Lunai Bioworks Inc. Retains American Defense International | RENB Stock News - GuruFocus
Renovaro BioSciences to change corporate name to ‘Lunai Bioworks’ - MSN
Order flow analysis tools used on Renovaro Inc.July 2025 Selloffs & Verified Entry Point Detection - Newser
Published on: 2025-08-28 20:54:17 - Newser
Applying Elliott Wave Theory to Renovaro Inc.2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
Chart overlay techniques for tracking Renovaro Inc.Weekly Trade Analysis & Risk Controlled Swing Alerts - Newser
Will Renovaro Inc. stock go up soonWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
What earnings revisions data tells us about Renovaro Inc.Trade Performance Summary & Growth Focused Entry Point Reports - Newser
Quantitative breakdown of Renovaro Inc. recent moveIPO Watch & Expert Curated Trade Ideas - Newser
Evaluating Renovaro Inc. with trendline analysisJuly 2025 Fed Impact & Stock Portfolio Risk Management - Newser
Applying Wyckoff theory to Renovaro Inc. stockJuly 2025 Drop Watch & Capital Protection Trading Alerts - Newser
Can volume confirm reversal in Renovaro Inc.2025 Market Sentiment & Community Driven Trade Alerts - Newser
When is the best time to exit Renovaro Inc.Weekly Stock Analysis & Low Risk Growth Stock Ideas - Newser
can renovaro inc. stock recover from recent declineJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - Newser
Published on: 2025-08-27 22:01:42 - Newser
Is Renovaro Inc. a candidate for recovery playWeekly Stock Summary & Weekly High Potential Alerts - Newser
What the charts say about Renovaro Inc. todayBull Run & Free Long-Term Investment Growth Plans - Newser
Published on: 2025-08-27 19:26:06 - Newser
Can technical indicators confirm Renovaro Inc.’s reversalQuarterly Market Summary & AI Forecast for Swing Trade Picks - Newser
Is Renovaro Inc. forming bullish engulfing patterns2025 Market Sentiment & Stock Market Timing Techniques - sundaytimes.kr
Renovaro Inc. stock retracement – recovery analysis2025 Technical Overview & Risk Controlled Swing Trade Alerts - Newser
Renovaro Rebrands to Lunai Bioworks, Emphasizing AI in Biodefense - AInvest
Renovaro (RENB) Rebrands to Lunai Bioworks, Emphasizing AI in Bi - GuruFocus
Published on: 2025-08-27 10:45:40 - Newser
Advanced analytics toolkit walkthrough for Renovaro Inc.2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on - PharmiWeb.com
Lunai Bioworks: Building a Defensible Moat with AI-Driven Biotechnology in High-Growth Markets - AInvest
Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics | RENB Stock News - GuruFocus
Renovaro Inc. Changes Name to Lunai Bioworks, Focusing on AI-Driven Biodefense and Drug Discovery. - AInvest
How to contact the Daily Bulletin - FinancialContent
Exit strategy if you’re trapped in Renovaro Inc.Weekly Earnings Recap & Real-Time Chart Breakout Alerts - Newser
Lunai Bioworks Inc Stock (RENB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):